Anti-SLITRK6 Antibody (Sirtratumab vedotin)
Catalog No.
F1561
Anti-SLITRK6 Antibody (Sirtratumab vedotin)
Featured Products
Sirtratumab Vedotin (ASG-15ME) is an antibody-drug conjugate (ADC) consisting of SLTRK6 (SLIT and NTRK-like family, member 6) and the cytotoxic monomethyl auristatin E (MMAE). It delivers a small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE), to tumor cells expressing SLITRK6. Sirtratumab Vedotin has the potential to be used in bladder cancer and metastatic urothelial carcinoma research.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1824663-83-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
AGS-15E, AGS15C–SGD-1006
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9H5Y7
Human
MMAE
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
SLITRK6
Please avoid freeze-thaw cycles.